URIST MARSHALL disclosed sale in Royalty Pharma plc | TradingNote AI

TNTradingNote AI

Back to daily briefing

URIST MARSHALLSaleRPRXInsider Trade

URIST MARSHALL disclosed sale in Royalty Pharma plc

URIST MARSHALL disclosed a sale transaction in Royalty Pharma plc (RPRX) on 2026-05-21.

Action

Sale

Capital

$721,838 reported value

Insider Form 4 Activity1 evidence source

Why it matters

This signal is anchored to the Form 4 disclosure date from Dataroma insider data.

Evidence

URIST MARSHALL insider Form 4 disclosure for RPRX

Filed 2026-05-21 21:20:00+00 · Period end 2026-05-21 · https://www.sec.gov/Archives/edgar/data/1838139/000183813926000018/xslF345X03/wk-form4_1779412810.xml:1838139:RPRX:2026-05-20:Sale:13684:721838:D

Related Cards

SaleCVS

ROBBINS LARRY

ROBBINS LARRY disclosed a sale transaction in CVS HEALTH Corp (CVS) on 2026-05-21.

SaleCVS

ROBBINS LARRY

ROBBINS LARRY disclosed a sale transaction in CVS HEALTH Corp (CVS) on 2026-05-21.

SaleWTTR

CRESTVIEW PARTNERS II GP, L.P.

CRESTVIEW PARTNERS II GP, L.P. disclosed a sale transaction in Select Water Solutions Inc (WTTR) on 2026-05-21.

URIST MARSHALL disclosed sale in Royalty Pharma plc | TradingNote AI